#ESCCongress – Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease – New England Journal of Medicine (free)

Editorial: Targeting Inflammation in Coronary Artery Disease (free)

Commentaries: Anti-Inflammatory Therapy for Atherosclerotic Disease: A Step Closer? – Physician’s First Watch (free) AND CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events – TCTMD (free) AND CANTOS Validates Role Of Inflammation In Heart Disease – Cardiobrief (free)

“This widely anticipated study delivered some modestly positive results (fewer nonfatal MIs), some worrisome results (increased fatal infections), and some unexpected results (fewer cancer deaths)” (from Physician’s First Watch).